Today, to mark the 15th anniversary of the FDA foreign offices, the FDA published an interview with Susan Winckler, who was FDA chief of staff when the first office was opened in Beijing on November 19, 2008.
A key focus for new National Institutes of Health (NIH) Director Monica Bertagnolli is spearheading innovative way to get more patients into in clinical trials to improve evidence generation, she said in recent remarks, including by getting providers more involved in trial enrollment.
On Aug. 14, 2023, U.S. Food and Drug Administration (FDA or the Agency) Commissioner Robert Califf provided an update on changes to the Agency’s dietary supplement program, under the proposed human foods program redesign.
The Reagan-Udall Foundation asserts in a new report that the current post-market evidence generation system is expensive and time-consuming, with an urgent need for substantial changes.
As the FDA seeks to bring a greater focus to improving post-market evidence generation, a new report from the Reagan-Udall Foundation offers some potential solutions to the system it says is too costly and complicated.
The notorious contamination of infant formula over the winter of 2021-22 was a scandal not only for Abbot Nutrition, the product’s manufacturer, but for the federal Food and Drug Administration (FDA), which dawdled for five months before taking action.
